Our observation of decreased glioma risk with higher levels of LIF was unexpected because this cytokine is a mediator of glioblastoma stem cell renewal [29] and a post- diagnostic case-control study of serum cytokines found higher levels of this cytokine among glioma cases than among controls [17]. Here, LIF is linked to central nervous system cancer.